Not intended for diagnostic, therapeutic, or personal use
Other frequently reported side effects associated with semaglutide may include headache, abdominal pain, nasopharyngitis, dizziness, gastroenteritis, constipation, and GERD.[2] Semaglutide has a boxed warning, or a serious safety warning by the FDA, for the risk of thyroid C-cell tumors.[2] Additional safety warnings and precautions are acute pancreatitis, gall bladder disease, kidney injury, increased heart rate, and hypersensitivity reactions
Tirzepatides dual GLP-1 and GIP receptor activity translates into enhanced metabolic and weight-loss benefits compared to GLP-1 monotherapy. While semaglutide remains a trusted choice for both diabetes and obesity, these findings suggest tirzepatide may offer an extra edge
If you've never had it, food noise can be tricky to picture
90.1% of patients achieved more than 10% weight loss compared to 13.5% on lifestyle changes alone 78.2% of patients achieved more than 15% weight loss compared to 6% on lifestyle changes alone
M.CarlS
